Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glargine + aspart versus NPH + regular insulin in children with type 1 diabetes
IRCT201203079224N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of insulin glargine, insulin aspart, insulin isophane and human insulin in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Tehran University of Medical Sciences. Started May 2012; status: completed.
02
Drugs
insulin glargineinsulin aspartinsulin isophanehuman insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on IRCT201203079224N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201203079224N1.